IGLL5 and breast carcinoma: IGLL5 is also correlated with glioblastoma survival and breast cancer, which could serve as a biomarker for relapse-free survival in breast cancer with more than 85% accuracy (Ascierto et al., 2012; Qin et al., 2020).